190 related articles for article (PubMed ID: 22506050)
1. Fifteen-year population attributable fractions and causal pies of risk factors for newly developed hepatocellular carcinomas in 11,801 men in Taiwan.
Liao SF; Yang HI; Lee MH; Chen CJ; Lee WC
PLoS One; 2012; 7(4):e34779. PubMed ID: 22506050
[TBL] [Abstract][Full Text] [Related]
2. The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network.
Chang IC; Huang SF; Chen PJ; Chen CL; Chen CL; Wu CC; Tsai CC; Lee PH; Chen MF; Lee CM; Yu HC; Lo GH; Yeh CT; Hong CC; Eng HL; Wang J; Tseng HH; Hsiao CH; Wu HI; Yen TC; Liaw YF
Medicine (Baltimore); 2016 Apr; 95(15):e3284. PubMed ID: 27082566
[TBL] [Abstract][Full Text] [Related]
3. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
[TBL] [Abstract][Full Text] [Related]
4. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
5. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study.
Tagger A; Donato F; Ribero ML; Chiesa R; Portera G; Gelatti U; Albertini A; Fasola M; Boffetta P; Nardi G
Int J Cancer; 1999 May; 81(5):695-9. PubMed ID: 10328218
[TBL] [Abstract][Full Text] [Related]
6. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan.
Wang LY; You SL; Lu SN; Ho HC; Wu MH; Sun CA; Yang HI; Chien-Jen C
Cancer Causes Control; 2003 Apr; 14(3):241-50. PubMed ID: 12814203
[TBL] [Abstract][Full Text] [Related]
7. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.
Chen CL; Yang HI; Yang WS; Liu CJ; Chen PJ; You SL; Wang LY; Sun CA; Lu SN; Chen DS; Chen CJ
Gastroenterology; 2008 Jul; 135(1):111-21. PubMed ID: 18505690
[TBL] [Abstract][Full Text] [Related]
8. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
Tseng TC; Liu CJ; Hsu CY; Hong CM; Su TH; Yang WT; Chen CL; Yang HC; Huang YT; Fang-Tzu Kuo S; Liu CH; Chen PJ; Chen DS; Kao JH
Gastroenterology; 2019 Dec; 157(6):1518-1529.e3. PubMed ID: 31470004
[TBL] [Abstract][Full Text] [Related]
9. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
10. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
11. Population attributable fractions of risk factors for hepatocellular carcinoma in the United States.
Makarova-Rusher OV; Altekruse SF; McNeel TS; Ulahannan S; Duffy AG; Graubard BI; Greten TF; McGlynn KA
Cancer; 2016 Jun; 122(11):1757-65. PubMed ID: 26998818
[TBL] [Abstract][Full Text] [Related]
12. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.
Welzel TM; Graubard BI; Quraishi S; Zeuzem S; Davila JA; El-Serag HB; McGlynn KA
Am J Gastroenterol; 2013 Aug; 108(8):1314-21. PubMed ID: 23752878
[TBL] [Abstract][Full Text] [Related]
13. Etiological and molecular profile of hepatocellular cancer from India.
Asim M; Sarma MP; Kar P
Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
[TBL] [Abstract][Full Text] [Related]
14. Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan.
Sun CA; Wu DM; Lin CC; Lu SN; You SL; Wang LY; Wu MH; Chen CJ
Am J Epidemiol; 2003 Apr; 157(8):674-82. PubMed ID: 12697571
[TBL] [Abstract][Full Text] [Related]
15. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
[TBL] [Abstract][Full Text] [Related]
16. Perspectives and control of hepatitis B virus infection in Taiwan.
Lin CL; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):901-9. PubMed ID: 26184565
[TBL] [Abstract][Full Text] [Related]
17. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations.
Sarin SK; Thakur V; Guptan RC; Saigal S; Malhotra V; Thyagarajan SP; Das BC
J Gastroenterol Hepatol; 2001 Jun; 16(6):666-73. PubMed ID: 11422620
[TBL] [Abstract][Full Text] [Related]
18. Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis.
Shi Y; Wu YH; Wu W; Zhang WJ; Yang J; Chen Z
Liver Int; 2012 Feb; 32(2):231-40. PubMed ID: 21745272
[TBL] [Abstract][Full Text] [Related]
19. What can we learn from hepatitis B virus clinical cohorts?
Lin CL; Tseng TC; Kao JH
Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
[TBL] [Abstract][Full Text] [Related]
20. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan.
Lu SN; Su WW; Yang SS; Chang TT; Cheng KS; Wu JC; Lin HH; Wu SS; Lee CM; Changchien CS; Chen CJ; Sheu JC; Chen DS; Chen CH
Int J Cancer; 2006 Oct; 119(8):1946-52. PubMed ID: 16708389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
